Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scale Biosciences has developed and commercialized advanced single cell omics platforms—QuantumScale and ScalePlex—that enable massively scalable and cost-effective single cell experiments. Their products are used globally by researchers to generate high-throughput data for applications such as transcriptomics and epigenomics. The company’s technologies have been adopted in major collaborative projects like the Chan Zuckerberg Initiative’s Billion Cells Project. No clinical results apply as they do not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scale Biosciences.